Keyphrases
Schizophrenia
100%
Severe Mental Illness
100%
Decanoate
100%
Zuclopenthixol
100%
Confidence Interval
38%
Depot Preparations
30%
Antipsychotics
23%
Depot
23%
Number-needed-to-treat
23%
Adverse Effects
15%
Psychotic Symptoms
15%
Service Utilization
15%
Quality of Life
7%
Health Outcomes
7%
Disability
7%
Inclusion Criteria
7%
Odds Ratio
7%
Cochrane Library
7%
Embase
7%
Dichotomous Data
7%
MEDLINE
7%
Cochrane
7%
Clinical Judgment
7%
Schizophrenia Treatment
7%
Carers
7%
Relapse Rate
7%
Controlled Experiment
7%
Regular Basis
7%
Trial Data
7%
Missing Data
7%
Issue 2
7%
Oral Medication
7%
Satisfaction with Care
7%
People with Schizophrenia
7%
CINAHL
7%
Utilization Data
7%
Economic Outcomes
7%
Electronic Search
7%
Care Recipient
7%
Utilization Costs
7%
Reporting Services
7%
Utilization Quality
7%
Drug-induced Movement Disorders
7%
Nursing and Health Professions
Zuclopenthixol Decanoate
100%
Diseases
100%
Confidence Interval
50%
Numbers Needed to Treat
30%
Zuclopenthixol
30%
Mental Diseases
20%
Odds Ratio
10%
Cochrane Library
10%
Motor Dysfunction
10%
PsycINFO
10%
Cholinergic Receptor Blocking Agent
10%
Recurrence Risk
10%
CINAHL
10%
Clinical Judgment
10%
Quality of Life
10%
Pharmacology, Toxicology and Pharmaceutical Science
Zuclopenthixol Decanoate
100%
Diseases
100%
Antipsychotic
30%
Number Needed to Treat
30%
Zuclopenthixol
30%
Mental Diseases
20%
Clinical Study
10%
Recurrence Risk
10%
Controlled Clinical Trial
10%
Cholinergic Receptor Blocking Agent
10%
Motor Dysfunction
10%
Preference
10%